NXTSENS, a microtechnology company with expertise in medical diagnostic equipment is ranked among the World's top 60 emerging silicon companies.
NXTSENS is on its way to raising the investment needed for regulatory approval in order to launch its key product in fall 2017. McGill professors Vamsy Chodavarapu and Ed Harvey co-founded the company in January 2015 with several researchers and students that shared a belief in the groundbreaking technology that has in large part been funded by a highly competitive CHRP federal grant. NXTSENS has developed an accurate diagnosing tool for trauma injuries. Our team works directly with surgeons to deliver the best possible solution; bridging the gap between technology and medicine.